GlobeNewswire

Stratumn raises largest funding round to date in the European blockchain and data security ecosystem

Dela

PARIS, June 08, 2017 (GLOBE NEWSWIRE) -- Stratumn, a leading provider of network solutions securing processes between enterprises and their stakeholders through blockchain technology and advanced cryptography, announces today the raising of €7M in a series A funding from Open CNP, the Corporate Venture arm of CNP Assurances, Otium Venture, Nasdaq and Digital Currency Group.

Less than two years after its inception and one year after its seed financing, Stratumn has now accomplished the largest funding round to date in the European blockchain and data security ecosystem.

Stratumn helps companies securing and streamlining regulatory and compliance procedures

As companies become ever more connected to one another, and the security and integrity of their data is challenged, centrally managed information systems have proved their limitations. Stratumn's Proof of Process Technology solves a core dilemma for organizations: streamlining regulatory and compliance procedures, improving customer privacy and data protection, while reducing operational and back office costs. Stratumn's suite of network solutions provides organizations with an efficient and reliable way to streamline and secure the exchange of data between partners, customers, and regulators. Enterprises who adopt this technology benefit from better accountability, traceability and integrity of their records, while regulators may audit process data in real-time.

Stratumn has already developed more than 10 projects with large companies such as CNP Assurances, Allianz France, Nasdaq, Thales, Bureau Veritas or Bouygues Immobilier, and is currently France's leading company using the blockchain technology in terms of staff and projects development.

The funding will accelerate Stratumn's development and expansion into the U.S.

This funding round constitutes a major step for Stratumn, as it will allow the company to accelerate its development, notably by focusing on research, product design, and business development, as well as by continuing to attract talented individuals to join its 15-person strong international team - the company aims to double its size by the end of 2018. Stratumn also intends to develop its international activities through a planned expansion into the United States by the end of the year. This would allow the company to become closer to key stakeholders and decision centres in their core market segments.  

This round, led by Open CNP, the Corporate Venture arm of CNP Assurances, with the participation of Nasdaq, Digital Currency Group and existing investor Otium Venture, combines major corporate and financial investors from France and the United States. In addition to enabling Stratumn's development through additional funding, these investors will support Stratumn's growth in their respective fields and geographies through partnerships and knowledge sharing, which will help the company reinforce its existing links with the insurance, capital markets and digital currency ecosystems.

Stratumn and Nasdaq have also entered into a co-research and development partnership, which aims at leveraging Proof of Process Technology to enhance the software solutions and products for the capital markets, particularly in Nasdaq's Market Technology business and its own enterprise technology unit.

Richard Caetano, Co-founder and CEO of Stratumn declared: "We are very pleased to have successfully closed this series A round, which represents a major milestone for Stratumn. Our new investors will enable Stratumn to continue and accelerate its development and more effectively address growing needs in our markets. We are especially happy with the continued and increased support from Otium Venture, who have accompanied us for a year, and excited to welcome CNP Assurances, Nasdaq and Digital Currency Group, who will help us reinforce Stratumn's presence in the insurance and capital markets sectors. We are very confident about Stratumn's development prospects in the upcoming months and years. The successful closing of this round, as well as our investor's commitment as strategic partners, is rocket fuel which will power the development and launch of Proof of Process Technology."

Magali Noé, CDO of CNP Assurances said: " Blockchain technology makes processes more reliable and streamlines information flows for consortiums. We would like to promote this technology to our partners and to insurance industry players using the Proof of Process Technology developed by Stratumn. This investment is part of the €100 million that CNP Assurances allocates to start-ups over a five-year period through its Open CNP programme and is the fourth Open CNP investment to date." 

Bruno Raillard, Partner at Otium Venture, added: " We have been strong supporters since Stratumn's seed round one year ago. We were struck by the clarity and ambition of Richard's vision: enabling companies to embed security, traceability and transparency into their mission-critical business processes. The opportunity is massive. It's not about the $40bn+ of potential savings on compliance and back-office costs in capital markets, insurance and energy alone; it's about building the layer of trust that the network economy really needs to blossom. We're thrilled to see Stratumn grow and to be part of this important step."

Nasdaq Head of Corporate Strategy Jean-Jacques Louis said: "An investment in Stratumn was a natural development for us given the experimentation projects we have successfully executed with Richard and his team over the past year. We look forward to furthering our relationship between Stratumn and our technology team by collaborating on developing and applying unique financial technology that will bolster and strengthen the current and next generation products for our customers and ourselves. This approach fits with the mission of Nasdaq and, in particularly, our newly formed  Nasdaq Ventures ."

Digital Currency Group CEO Barry Silbert said: "We are eager to have Stratumn join the DCG family, which now includes 100 companies across 28 countries. Stratumn's Proof of Process Technology solves critical challenges around verifying and auditing the integrity of data used to make critical business decisions, and we look forward to helping the team build partnerships across our network of blockchain service providers and enterprises."

About Stratumn: Founded in Paris in 2015 by Richard Caetano, an American entrepreneur, Stephan Florquin and Sebastien Couture, Stratumn develops network technology to secure processes between enterprise partners, customers and regulators. Its Proof of Process Technology combines blockchain networks and advanced cryptography to streamline and secure the critical processes between organizations while insuring data privacy and reducing operational frictions and costs. Learn more at www.stratumn.com or follow @StratumnHQ for updates on Stratumn.

About CNP Assurances: CNP Assurances is France's leading personal insurer with net profit of €1,200 million in 2016. The Group also has operations in other European countries and in Latin America, with a significant presence in Brazil. It has more than 35 million personal risk/protection insureds worldwide and more than 14 million savings and pensions policyholders. For 160 years, CNP Assurances has been protecting people against the risks of everyday life. The Group designs and manages life insurance, pension, personal risk insurance and protection products (term creditor insurance and health insurance). CNP Assurances has been listed on the first market of the Paris Stock Exchange since 1998 and has a stable shareholder structure thanks to the signing of an agreement between its major shareholders (Caisse des Dépôts, La Banque Postale, Groupe BPCE and the French State).  

About Otium Venture: Otium is a thesis-driven, early-stage European VC, backing the founders building the creative society. Otium Venture is Otium's tech-focused team, investing in startups that create value through software, data and network effects. To learn more, please visit: otiumcapital.com.

About Nasdaq: Nasdaq (Nasdaq:NDAQ) is a leading global provider of trading, clearing, exchange technology, listing, information and public company services. Through its diverse portfolio of solutions, Nasdaq enables customers to plan, optimize and execute their business vision with confidence, using proven technologies that provide transparency and insight for navigating today's global capital markets. As the creator of the world's first electronic stock market, its technology powers more than 89 marketplaces in 50 countries, and 1 in 10 of the world's securities transactions. Nasdaq is home to 3,800 total listings with a market value of $11 trillion. To learn more, visit:  http://business.nasdaq.com

About Digital Currency Group: Digital Currency Group builds and supports bitcoin and blockchain companies by leveraging its insights, network, and access to capital. Based in New York City, DCG is the most active investor in the blockchain industry with over 100 investments in nearly 30 countries. Visit www.dcg.co or follow @DCGCo for updates on DCG and its dynamic ecosystem.

Cautionary Note Regarding Forward-Looking Statements

The matters described herein contain forward-looking statements that are made under the Safe Harbor provisions of the Private Securities Litigation Reform Act of 1995. These statements include, but are not limited to, statements about Nasdaq and its products and offerings. We caution that these statements are not guarantees of future performance. Actual results may differ materially from those expressed or implied in the forward-looking statements. Forward-looking statements involve a number of risks, uncertainties or other factors beyond Nasdaq's control. These factors include, but are not limited to factors detailed in Nasdaq's annual report on Form 10-K, and periodic reports filed with the U.S. Securities and Exchange Commission. We undertake no obligation to release any revisions to any forward-looking statements.

NDAQG

Media contacts

Stratumn - Brunswick Group - stratumn@brunswickgroup.com 

France: Domitille Harb, Tristan Bourassin
+33 (0) 1 53 96 83 83

USA: Brunswick San Francisco 
+1 415 671 7676

CNP Assurances - servicepresse@cnp.fr

Florence de Montmarin, Tamara Bernard
+33 (0) 1 42 18 86 51 / +33 (0) 1 42 18 86 19

Otium Venture - gabriela@otiumcapital.com

Gabriela Salord
+33 (0) 6 79 90 27 07

Nasdaq - ryan.wells@nasdaq.com  

Ryan Wells
Direct: +44 (0) 20 3753 2231
Mobile:  +44 (0) 7809 596 390 

Digital Currency Group - press@dcg.co 




This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Nasdaq via Globenewswire

Om

GlobeNewswire



Följ GlobeNewswire

Abonnera på våra pressmeddelanden.

Senaste pressmeddelandena från GlobeNewswire

Stillfront: Simutronics återtar förläggartjänster10.12.2018 14:11Pressmeddelande

PRESSMEDDELANDE 2018-12-10 Simutronics återtar förläggartjänster för SIEGE: Titan Wars globalt med undantag för Kina Simutronics, en studio inom Stillfront Group, har avslutat ett medförläggaravtal avseende mobilspelet SIEGE: Titan Wars med den New York-baserade förläggarpartnern Tilting Point. Enligt ett nytt avtal kommer Tilting Point fortsatt att tillhandahålla förläggartjänster och marknadsföring av spelet i Kina men på global nivå kommer Simutronics att ansvara för förläggartjänster och marknadsföring av spelet från gruppen. Simutronics är en ledande utvecklare av rollspel och mobila spel som till exempel DragonRealms, GemStone IV och Lara Croft Relic Run, den sistnämnda med mer än 23 miljoner nedladdningar. Tilting Point är den nya generationens spelbolagspartner som förser ledande utvecklingsstudios med expertis, tjänster och operationell support för att optimera högkvalitativa livespel framgångsrikt. "Jag är mycket nöjd över det fortsatta partnerskapet med Tilting Point för den

Stillfront: Simutronics reclaims publishing services10.12.2018 14:11Pressmeddelande

PRESS RELEASE December 10, 2018 Simutronics reclaims the publishing services for SIEGE: Titan Wars globally except China Simutronics Corp, a studio within Stillfront Group AB, has ended a co-publishing agreement regarding the mobile game SIEGE: Titan Wars with New York based publishing partner Tilting Point. According to a new agreement, Tilting Point will continue to provide publishing services and market the game in China but Simutronics will run the publishing services and marketing globally from the Group going forward. Simutronics is a leading developer of online roleplaying and mobile games such as DragonRealms, GemStone IV and Lara Croft Relic Run, the latter with more than 23 million downloads. Tilting Point is a new-generation games partner that provides top development studios with expert resources, services, and operational support to optimize high quality live games for success. "I am very pleased to continue the partnership with Tilting Point for the Chinese market as this

Karolinska Development's portfolio company Aprea Therapeutics presents continued positive results from a Phase Ib/II study of APR 2462.12.2018 18:00Pressmeddelande

STOCKHOLM, December 2, 2018. Karolinska Development's portfolio company Aprea Therapeutics today presented positive clinical results for its drug candidate APR 246 at the 2018 American Society of Hematology (ASH) Annual Meeting in San Diego, US. An Overall Response Rate of 95% and a Complete Remission (CR) rate of 70% were achieved in an ongoing Phase I/II combination study of APR 246 and azacitidine (AZA) for the treatment of TP53 mutated Myelodysplastic Syndrome (MDS). No dose-limiting toxicities have been observed. Based on these encouraging data, Aprea intends to progress APR 246 into a Phase III study in the near future. The results presented at the ASH meeting is based on 20 patients with TP53 mutated MDS. The overall response rate was 95%, and 14 (70%) patients achieved a complete remission at data cutoff. These findings were accompanied by a deep molecular remission in the majority of patients as assessed by serial TP53 analysis. No dose-limiting toxicities have been experience

Karolinska Development's portfolio company Aprea Therapeutics presents continued positive results from a Phase Ib/II study of APR 2462.12.2018 18:00Pressmeddelande

STOCKHOLM, December 2, 2018. Karolinska Development's portfolio company Aprea Therapeutics today presented positive clinical results for its drug candidate APR 246 at the 2018 American Society of Hematology (ASH) Annual Meeting in San Diego, US. An Overall Response Rate of 95% and a Complete Remission (CR) rate of 70% were achieved in an ongoing Phase I/II combination study of APR 246 and azacitidine (AZA) for the treatment of TP53 mutated Myelodysplastic Syndrome (MDS). No dose-limiting toxicities have been observed. Based on these encouraging data, Aprea intends to progress APR 246 into a Phase III study in the near future. The results presented at the ASH meeting is based on 20 patients with TP53 mutated MDS. The overall response rate was 95%, and 14 (70%) patients achieved a complete remission at data cutoff. These findings were accompanied by a deep molecular remission in the majority of patients as assessed by serial TP53 analysis. No dose-limiting toxicities have been experience

Corline Biomedical AB: Patientrekrytering startar i Renaparin-studie30.11.2018 16:37Pressmeddelande

Corline Biomedical AB ("Corline" eller "Bolaget") meddelar idag att patientrekrytering i den kliniska fas 1-studien RENAPAIR-01 startar. I studien utvärderas bolagets läkemedelskandidat Renaparin® som är under utveckling för att förbättra utfallet av njurtransplantation. Patienter kommer inledningsvis att rekryteras på Akademiska sjukhuset i Uppsala. När de fyra första patienterna utvärderats inleds också rekrytering på Karolinska Universitetssjukhuset i Huddinge. Beskedet att patientrekrytering startar innebär att förberedelsearbetet inför studiestart är avslutat och att till exempel avtal, initieringsmöte, logistik, provhantering och monitorering är hanterat, samt att godkänt prövningsläkemedel nu finns tillgängligt för rekvirering av kirurgerna på transplantationskliniken i Uppsala för dosering till donatornjurar. När första patient doserats kommer detta meddelas separat. Corline har utvecklat och äger rättigheterna till Renaparin® som administreras direkt till den donerade njuren i

Stillfront: Bytro Labs lanserar en ny version av Supremacy 191427.11.2018 08:00Pressmeddelande

PRESSMEDDELANDE 2018-11-27 Bytro Labs, en studio inom Stillfront Group, lanserar en ny version av Supremacy 1914 Spelutvecklaren Bytro Labs, mest kända för sitt framgångsrika strategispel Call of War, har släppt en ny version av sin klassiska speltitel Supremacy 1914. Dagens lansering är den första av tre milstolpar för den nya versionen av Supremacy 1914 - The Great War som släpps 2019. Den första uppdateringen innehåller en komplett omarbetning av området för spelets community, ett nytt utseende för kartan samt ny 3D-teknologi. I nästa steg kommer Bytro Labs att gå vidare till "true cross platform" där spelet tillgängliggörs för fler plattformar, en strategi som tidigare har varit framgångsrik för titeln Call of War. Supremacy 1914 - The Great War släpps för Android senare i år och i början av 2019 släpps spelet för iOS och Steam. Det tredje och sista steget i lanseringen kommer i mitten av 2019 innehållande en större uppdatering avseende både innehåll och funktion, som färdigställer

I vårt pressrum kan du läsa de senaste pressmeddelandena, få tillgång till pressmaterial och hitta kontaktinformation.

Besök vårt pressrum